Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gproan VLP influenza vaccine
- Development stage
- Preclinical
- Lead developer
- Gproan Biotech
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Gproan VLP influenza vaccine is a virus-like particle (VLP) vaccine candidate developed by Gproan Biotech for the prevention of influenza. The vaccine is produced using a baculovirus expression system in insect cell cultures, a platform designed to present a broader panel of influenza antigens, such as hemagglutinin and neuraminidase, in their native conformation. Unlike traditional egg-based vaccines, this VLP approach mimics the structure of the influenza virus without containing infectious genetic material, potentially offering enhanced immunogenicity and a more efficient manufacturing process. The candidate is currently in preclinical development.
- Other names
- Gproan influenza VLP vaccineGproan Biotech VLP influenza vaccine
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on Gproan VLP influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gproan VLP influenza vaccine.